Loading...
Drug Developer Begins Trial of Autism Treatment
Research
Drug Developer Begins Trial of Autism Treatment
2022-02-02 17:29:14
by Alexa Hornbeck

WASHINGTON — Yamo Pharmaceuticals recently enrolled its first patient in a phase 2 clinical trial that may result in medicines able to treat the core behaviors of autism spectrum disorder. “There are 20 million or more people with autism around... Read More

Straight From The Well